Foods (Oct 2022)

The Effect of Indole-3-Lactic Acid from <i>Lactiplantibacillus plantarum</i> ZJ316 on Human Intestinal Microbiota In Vitro

  • Qingqing Zhou,
  • Zuorui Xie,
  • Danli Wu,
  • Lingli Liu,
  • Yongqing Shi,
  • Ping Li,
  • Qing Gu

DOI
https://doi.org/10.3390/foods11203302
Journal volume & issue
Vol. 11, no. 20
p. 3302

Abstract

Read online

Microbiota-derived tryptophan metabolites are essential signals for maintaining gut homeostasis, yet the potential contribution to modulating gut microbiota has been rarely investigated. In this study, Lactiplantibacillus plantarum ZJ316 (CCTCC No. M 208077) with a high production (43.14 μg/mL) of indole-3-lactic acid (ILA) was screened. ILA with 99.00% purity was prepared by macroporous resin, Sephadex G–25 and reversed-phase high-performance liquid chromatography. Purified ILA can effectively inhibit foodborne pathogens such as Salmonella spp., Staphylococcus spp., Escherichia coli and Listeria monocytogenes. In an in vitro model of the human gut microbiota, a medium-dose ILA (172 mg/L) intervention increased the average relative abundance of phyla Firmicutes and Bacteroidota by 9.27% and 15.38%, respectively, while Proteobacteria decreased by 14.36% after 24 h fermentation. At the genus level, the relative abundance of Bifidobacterium and Faecalibacterium significantly increased to 5.36 ± 2.31% and 2.19 ± 0.77% (p Escherichia and Phascolarctobacterium decreased to 16.41 ± 4.81% (p p p Oscillospira and Collinsella. Overall, ILA has the potential to regulate the gut microbiota, and an in-depth understanding of the relationship between tryptophan metabolites and gut microbiota is needed in the future.

Keywords